- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04471012
The Transtheoretical Model For Polycystic Ovary Syndrome
Impact of The Individual Counseling Program Using The Transtheoretical Model For Polycystic Ovary Syndrome Management Among University Students
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Afyonkarahisar, Turkey, 03200
- Afyonkarahisar Health Science University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- voluntary participation
- absence of sexual activity
- belonging to the age group of 19-24
- absence of chronic diseases
- absence of any physical disability and a lack of mental disorders.
Exclusion Criteria:
- being on medicine
- scores of above 18.5 and below 30 on the Body Mass Index (BMI)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Individual counselling program
An individual counseling program that was based on TM and included motivational interview techniques was given to the experimental group which involved general information about the importance of weight control, healthy diet, and exercise. The experimental group was given a Benefits of Healthy Diet and Physical Activity in PCOS Training Booklet during their first counseling session. |
An individual counseling program that was based on TM and included motivational interview techniques was given to the experimental group which involved general information about the importance of weight control, healthy diet, and exercise. Benefits of Healthy Diet and Physical Activity in PCOS Training Booklet was given during their first counseling session. |
No Intervention: Standard Care
The progress of the participants in the control group was tracked routinely without any specific implementation.
At the end of the study, the control group was also given the same booklet.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Anthropometric Measurement
Time Frame: 1st month
|
Anthropometric measurements that are frequently used to evaluate the nutritional status of the individuals are weight and height will be combined to report BMI in kg/m2.
|
1st month
|
Anthropometric Measurement Change
Time Frame: 3rd month
|
Anthropometric measurements that are frequently used to evaluate the nutritional status of the individuals are weight and height will be combined to report BMI in kg/m2.
|
3rd month
|
Anthropometric Measurement Change
Time Frame: 5th month
|
Anthropometric measurements that are frequently used to evaluate the nutritional status of the individuals are weight and height will be combined to report BMI in kg/m2.
|
5th month
|
Collaborators and Investigators
Investigators
- Principal Investigator: Dilek OCALAN, PhD, Afyonkarahisar Health Science University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 205-84
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Polycystic Ovary Syndrome
-
Cairo UniversityCompleted
-
Alexandria UniversityRecruitingPolycystic Ovary Syndrome (PCOS)Egypt
-
Saudi German Hospital - MadinahCompletedPolycystic Ovary Syndrome (PCOS)Saudi Arabia
-
University of CopenhagenCompletedPolycystic Ovary Syndrome (PCOS)Denmark
-
Odense University HospitalCompleted
-
Assaf-Harofeh Medical CenterUnknownInfertility | Polycystic OvariesIsrael
-
Poznan University of Medical SciencesUniversity of California, DavisUnknownPolycystic Ovary Syndrome (PCOS)Poland
-
Riphah International UniversityCompleted
-
Dexa Medica GroupCompletedPolycystic Ovary Syndrome (PCOS)Indonesia
-
Virginia Commonwealth UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...TerminatedPolycystic Ovary Syndrome (PCOS)United States
Clinical Trials on Individual counselling program
-
Jens Rikardt AndersenCompleted
-
Radboud University Medical CenterSorgente BV; Fresenius Kabi Nederland BVCompletedNeoplasms, Head and NeckNetherlands
-
Eivind MelandUniversity of AgderCompleted
-
Andalusian Regional Ministry of HealthAndaluz Health ServiceUnknownTobacco Smoking | Hypercholesterolemia | High Blood Pressure
-
University of JenaCompletedReduction of Cardiovascular Risk FactorsGermany
-
Norwegian University of Science and TechnologyCompletedFecal Incontinence | Staffs' AttitudesNorway
-
Rosimeire Simprini PadulaUnknownMusculoskeletal Disorder of the NeckBrazil
-
Zealand University HospitalRegion Zealand; The Danish Working Environment AuthorityUnknownDermatitis | Eczema | Skin DiseaseDenmark
-
Fundacion para la Investigacion y Formacion en...Instituto de Investigación Biomédica de SalamancaCompletedCardiovascular Risk FactorSpain
-
Ohio State University Comprehensive Cancer CenterNational Cancer Institute (NCI)Completed